Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47

Benzinga Newsdesk www.benzinga.com Negative 92.8%

Neg 92.8% Neu 0% Pos 0%

Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.